STX6 and hepatocellular carcinoma: Argonaute-CLIP sequencing in human and mice identified novel miR-122 targets, such as B cell lymphoma 9 (BCL9), Solute carrier family 25 member 2 (SLC52A2) and Syntaxin 6 (STX6), that could predict survival in HCC patients [97].